Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grannum R Sant

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Reviews in Urology|September 21, 2006
Etiology, pathogenesis, and diagnosis of interstitial cystitisGrannum R Sant
Urology|April 28, 2007
Current diagnosis of interstitial cystitis: an evolving paradigmRobert J Evans, Grannum R Sant
The Canadian Journal of Urology|August 15, 2022
How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary careJudd W Moul, Grannum R Sant
Urology|April 28, 2007
Epidemiologic issues in interstitial cystitisJ Kellogg Parsons, Karlheinz Kurth, Grannum R Sant
The Urologic Clinics of North America|December 13, 2002
Current management of interstitial cystitisJames Chivian Lukban, Kristene E Whitmore, Grannum R Sant
NPJ Precision Oncology|June 7, 2018
Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?Grannum R Sant, Kevin B Knopf, David M Albala
Therapeutic Advances in Urology|September 24, 2024
Clinical use of nadofaragene firadenovec-vncgBadrinath R Konety, Neal D Shore, Grannum R Sant
Urology|April 28, 2007
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesisGrannum R Sant, Duraisamy Kempuraj, James E Marchand, et al.
Anesthesia and Analgesia|February 26, 2004
The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitisAndrew Sukiennik, Daniel B Carr, Iwona Bonney, et al.
Frontiers in Oncology|April 1, 2024
Mechanism of action of nadofaragene firadenovec-vncgVikram M Narayan, Joshua J Meeks, Jørn S Jakobsen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Reviews in Urology|September 21, 2006
Etiology, pathogenesis, and diagnosis of interstitial cystitisGrannum R Sant
Urology|April 28, 2007
Current diagnosis of interstitial cystitis: an evolving paradigmRobert J Evans, Grannum R Sant
The Canadian Journal of Urology|August 15, 2022
How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary careJudd W Moul, Grannum R Sant
Urology|April 28, 2007
Epidemiologic issues in interstitial cystitisJ Kellogg Parsons, Karlheinz Kurth, Grannum R Sant
The Urologic Clinics of North America|December 13, 2002
Current management of interstitial cystitisJames Chivian Lukban, Kristene E Whitmore, Grannum R Sant
NPJ Precision Oncology|June 7, 2018
Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?Grannum R Sant, Kevin B Knopf, David M Albala
Therapeutic Advances in Urology|September 24, 2024
Clinical use of nadofaragene firadenovec-vncgBadrinath R Konety, Neal D Shore, Grannum R Sant
Urology|April 28, 2007
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesisGrannum R Sant, Duraisamy Kempuraj, James E Marchand, et al.
Anesthesia and Analgesia|February 26, 2004
The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitisAndrew Sukiennik, Daniel B Carr, Iwona Bonney, et al.
Frontiers in Oncology|April 1, 2024
Mechanism of action of nadofaragene firadenovec-vncgVikram M Narayan, Joshua J Meeks, Jørn S Jakobsen, et al.
Pageof 2